Cochlear revealed more than $1.6 billion sales revenue and while the hearing device company's underlying profit lifted 18% to $277 million, its statutory profit slumped 11% to $289.1 million.
The company said that there was strong demand for acoustic implants and sound processor upgrades and all regions and product segments were tracking above pre-COVID levels.
?Our clear growth opportunity and strategy, combined with a strong balance sheet, mean we are well placed to create value for our stakeholders now, and over the long term,? saud CEO Dig Howitt.
Shares in Cochlear surged more than 7% on the back of the result.